|
Volumn 373, Issue 16, 2015, Pages 1580-1582
|
Response to idelalisib in a patient with stage IV Merkel-cell carcinoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IDELALISIB;
ANTINEOPLASTIC AGENT;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE;
PIK3CA PROTEIN, HUMAN;
PROTEIN KINASE INHIBITOR;
PURINE DERIVATIVE;
QUINAZOLINONE DERIVATIVE;
AGED;
CANCER RECURRENCE;
CANCER STAGING;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
GENE;
GENE MUTATION;
HUMAN;
HUMAN TISSUE;
LETTER;
LIVER BIOPSY;
LIVER METASTASIS;
MERKEL CELL TUMOR;
PIK3CA GENE;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
VERY ELDERLY;
ANTAGONISTS AND INHIBITORS;
CARCINOMA, MERKEL CELL;
GENETICS;
LIVER;
LIVER NEOPLASMS;
METABOLISM;
PATHOLOGY;
RADIOGRAPHY;
SCINTISCANNING;
SECONDARY;
SKIN TUMOR;
TUMOR CELL LINE;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, MERKEL CELL;
CELL LINE, TUMOR;
CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE;
FEMALE;
HUMANS;
LIVER;
LIVER NEOPLASMS;
NEOPLASM STAGING;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROTEIN KINASE INHIBITORS;
PURINES;
QUINAZOLINONES;
SKIN NEOPLASMS;
|
EID: 84944447424
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1507446 Document Type: Letter |
Times cited : (38)
|
References (5)
|